M
M. Ponzoni
Researcher at Vita-Salute San Raffaele University
Publications - 45
Citations - 1966
M. Ponzoni is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Diffuse large B-cell lymphoma & Lymphoma. The author has an hindex of 21, co-authored 45 publications receiving 1695 citations.
Papers
More filters
Journal ArticleDOI
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium Program Study
Carlo Visco,Yong Li,Zijun Y. Xu-Monette,Roberto N. Miranda,Tina Green,Alexandar Tzankov,Wanqing Wen,W-m Liu,Brad S. Kahl,Emanuele S.G. d'Amore,Santiago Montes-Moreno,Karen Dybkær,A Chiu,Wayne Tam,Attilio Orazi,Youli Zu,Govind Bhagat,Jane N. Winter,H-Y Wang,Stacey S O'Neill,Cherie H. Dunphy,Eric D. Hsi,Xianfeng Frank Zhao,Ronald S. Go,William W.L. Choi,Feng Zhou,Magdalena Czader,J. Tong,Xiaoying Zhao,J.H.J.M. van Krieken,Qin Huang,Weiyun Z. Ai,Joan E. Etzell,M. Ponzoni,Anna Ferreri,M A Piris,Michael Boe Møller,C. E. Bueso-Ramos,L J Medeiros,Lin Wu,Ken H. Young +40 more
TL;DR: An algorithm based on the expression of CD10, FOXP1 and BCL6 was developed that had a simpler structure than other recently proposed algorithms and 92.6% concordance with GEP and effectively predicts prognosis of DLBCL patients matching GEP subgroups in the era of rituximab therapy.
Journal ArticleDOI
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up✰
Emanuele Zucca,Luca Arcaini,Christian Buske,Peter Johnson,M. Ponzoni,Markus Raderer,Umberto Ricardi,Antonio Salar,K. Stamatopoulos,Catherine Thieblemont,A C Wotherspoon,M. Ladetto +11 more
Journal ArticleDOI
Relevance of intraocular involvement in the management of primary central nervous system lymphomas
A. J. M. Ferreri,Jean-Yves Blay,Michele Reni,Felice Pasini,A. Gubkin,Umberto Tirelli,A. Calderoni,Emanuele Zucca,Sergio Cortelazzo,Catherine Chassagne,M. Tinguely,B. Borisch,Françoise Berger,M. Ponzoni,Franco Cavalli +14 more
TL;DR: Chemotherapy combined with ocular irradiation resulted in better control of ocular disease, which seems to be associated with survival, and the use of chemotherapy alone in phase II trials should be critically reconsidered in PCNSL patients withOcular disease.
Journal ArticleDOI
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma
A. J. M. Ferreri,Elias Campo,Achille Ambrosetti,F. Ilariucci,John F. Seymour,Rein Willemze,G. Arrigoni,Giuseppe Rossi,Armando López-Guillermo,Emilio Berti,Mikael Eriksson,Massimo Federico,Sergio Cortelazzo,Silvia Govi,N. Frungillo,Stefania Dell'Oro,Maurizio Lestani,Silvia Asioli,Ennio Pedrinis,Marco Ungari,Teresio Motta,Riccardo L. Rossi,Tullio Artusi,Paolo Iuzzolino,Emanuele Zucca,F. Cavalli,M. Ponzoni +26 more
TL;DR: More intensive combinations, containing drugs with higher CNS bioavailability, are needed in cases with brain involvement, and the role of high-dose chemotherapy supported by ASCT should be further investigated in younger patients with unfavorable features.
Journal ArticleDOI
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
M.G. Della Porta,Erica Travaglino,Emanuela Boveri,M. Ponzoni,Luca Malcovati,Elli Papaemmanuil,Gian Matteo Rigolin,Cristiana Pascutto,Giorgio Alberto Croci,Umberto Gianelli,Raffaella Milani,Ilaria Ambaglio,Chiara Elena,Marta Ubezio,M C Da Via,Elisa Bono,Daniela Pietra,Federica Quaglia,Raffaella Bastia,Virginia Valeria Ferretti,Antonio Cuneo,E. Morra,Peter J. Campbell,Peter J. Campbell,Attilio Orazi,Rosangela Invernizzi,Mario Cazzola +26 more
TL;DR: A score to define minimal morphological criteria associated to the presence of marrow dysplasia was developed and showed high sensitivity/specificity, acceptable reproducibility and was independently validated.